Teva Pharma (TEVA) PT Trimmed to $49 at Maxim Group; 'Buy' Maintained
Tweet Send to a Friend
Maxim Group analyst Gabrielle Zhou lowered the price target on Teva Pharma (NYSE: TEVA) to $49.00 (from $52.00) after making ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
